SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COMMON STOCK
Total 13F shares
22,833,498
Share change
-8,482,521
Total reported value
$108,453,864
Put/Call ratio
165%
Price per share
$4.75
Number of holders
79
Value change
-$37,461,189
Number of buys
39
Number of sells
32

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q1 2019

As of 31 Mar 2019, SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,833,498 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, Wildcat Capital Management, LLC, Parametric Portfolio Associates LLC, BANK OF MONTREAL /CAN/, and DEUTSCHE BANK AG\. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.